Kingdon Capital Management, L.L.C. Uni Qure N.V. Transaction History
Kingdon Capital Management, L.L.C.
- $639 Million
- Q2 2025
A detailed history of Kingdon Capital Management, L.L.C. transactions in Uni Qure N.V. stock. As of the latest transaction made, Kingdon Capital Management, L.L.C. holds 200,000 shares of QURE stock, worth $13.6 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$13.6 Million% of portfolio
0.71%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding QURE
# of Institutions
192Shares Held
52.6MCall Options Held
4.43MPut Options Held
1.27M-
Rtw Investments, LP New York, NY5.16MShares$350 Million1.1% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$271 Million4.79% of portfolio
-
Vestal Point Capital, LP New York, NY3.7MShares$251 Million2.72% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.63MShares$246 Million0.92% of portfolio
-
Abrdn PLC2.75MShares$187 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $3.17B
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...